Arch Public
NVDAStocksCash yieldShort term

Cash Yield from a rising NVDA

Strategy #50 · NVDA daily · Market Wave · 1 Day chart

Backtested As of 8 Jul 2026 · 1 Jun 2024 – 1 Jun 2026 · $100,000 starting capital

Strategy return

+102.8%

Buy and hold NVDA

+82.8%

CAGR

42.5%

The chart

Every trade from the backtest, straight from TradingView.

Blue arrows: buys, with order sizeMagenta marks: sells1 Day bars
TradingView backtest chart of strategy #50 on NVDA, 1 Day, with every buy and sell marked

Against its benchmarks

NVDA daily+102.8%
Buy and hold NVDA+82.8%

Total return over the test period, backtested.

Past and backtested performance does not guarantee future results.

Results at your account size

$

Net profit

+$102,833

Ending value

$202,833

Cash profit

+$30,171

Asset accumulated

784 NVDA

We'll email this strategy's results at $100,000.

How it trades

Algorithm
Market Wave
Chart
1 Day
Horizon
Short term
Aim
Cash yield: aims for profit taken in cash
Test period
1 Jun 2024 – 1 Jun 2026
Starting capital
$100,000
Fees and slippage
Not stated
Data source
TradingView backtest

Exact settings come with every client account, the free tier included, in Strategy Lab Pro.

Start free
TradingView backtest chart of strategy #51 on NVDA, 1 Hour, with every buy and sell marked
NVDAStocksCash yield

Scalp Price Imbalances on NVDA

Strategy #51 · Market Wave · 1 Hour chart

Strategy+74.9%
Buy and hold NVDA+26.3%

Backtested · 22 Jul 2025 – 22 Jul 2026

TradingView backtest chart of strategy #77 on MRNA, 4 Hours, with every buy and sell marked
MRNAStocksCash yield

Trading the MRNA Pop

Strategy #77 · Market Wave · 4 Hours chart

Strategy+531.4%
Buy and hold MRNA+399.4%

Backtested · 1 Jan 2026 – 25 Aug 2026

Start free